Back to search

Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01

Data up to Jan 2025

Published1999
Citations24
References20

Total Citations Per Year

Abstract

References (20)

PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS

1972 • 1,130 citations

UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53

1996 • 451 citations

Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

1970 • 285 citations

Noncompartmental Analysis Based on Statistical Moment Theory

1982 • 274 citations

Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.

1996 • 221 citations

Potential roles for preclinical pharmacology in phase I clinical trials.

1986 • 213 citations

Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein.

1998 • 198 citations

UCN-01, a selective inhibitor of protein kinase C from Streptomyces.

1987 • 189 citations

Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.

1991 • 187 citations

G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.

1997 • 155 citations

Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells.

1993 • 133 citations

Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C

1993 • 119 citations

UCN-01, 7-Hydroxyl-staurosporine, Inhibits Kinase Activity of Cyclin-Dependent Kinases and Reduces the Phosphorylation of the Retinoblastoma Susceptibility Gene Product in A549 Human Lung Cancer Cell Line

1996 • 117 citations

Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells

1994 • 92 citations

Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor

1996 • 74 citations

Simple method of hepatic venous blood sampling in the rat

1976 • 46 citations

Application of Pharmacokinetically Guided Dose Escalation With Respect to Cell Cycle Phase Specificity

1994 • 25 citations

Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs

1989 • 25 citations

Cytocidal Action of Anticancer Agents : Evaluation of the Sensitivity of Cultured Animal and Human Cancer Cells

2015 • 24 citations

Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urine

1998 • 14 citations

Cited By (0)

No citing papers found in database

Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01 (1999) – Cancer Chemotherapy and Pharmacology | Metascience Observatory Explorer